Alembic Pharmaceuticals gets USFDA nod for generic eye treatment drug (Soban News)

The approval granted by USFDA is for the Abbreviated New Drug Application (ANDA) Difluprednate ophthalmic emulsion of strength 0.05 per cent​The approval granted by USFDA is for the Abbreviated New Drug Application (ANDA) Difluprednate ophthalmic emulsion of strength 0.05 per cent ​Home Page [ SOBAN NEWS: International and National ]